JPMORGAN CHASE & CO

Position in APGE — Apogee Therapeutics, Inc.

CIK 19617 NEW YORK, NY

Position in APGE

as of Jun 30, 2026 · filed Aug 12, 2026 Compact

Position Value

$47,683,248

-$45,785,008 QoQ

Shares Held

359,250

-67.6% QoQ

Ownership

0.475%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#42

of 285 holders

Holding Since

Sep 2023

12 quarters on record

Voting authority Sole 91% Shared 0% None 9%

Healthcare · as of Jun 30, 2026

JPMORGAN CHASE & CO holds $12,920,143,243 across 425 Biotechnology names. APGE ranks #33 (0.4% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	6,517,600	$3,237,487,438
2	REGN	Regeneron Pharmaceuticals, Inc.	3,774,199	$2,353,364,036
3	INSM	INSMED Inc	10,428,170	$1,111,851,478
4	ALNY	Alnylam Pharmaceuticals, Inc.	2,675,517	$805,410,876
5	RVMD	Revolution Medicines, Inc.	3,298,066	$617,661,794
6	RYTM	Rhythm Pharmaceuticals, Inc.	2,652,746	$294,534,385
7	JAZZ	Jazz Pharmaceuticals plc	1,160,786	$279,714,596
8	QURE	uniQure N.V.	4,867,755	$224,208,791

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$47,683,248	359,250	-67.6%	Shares	Other	2026-08-12
2026-03-31	$93,468,256	1,110,470	-19.1%	Shares	Other	2026-05-13
2025-12-31	$103,639,018	1,373,066	+20.7%	Shares	Other	2026-02-11
2025-09-30	$45,202,049	1,137,731	+1.1%	Shares	Other	2025-11-07
2025-06-30	$48,883,503	1,125,570	+16.9%	Shares	Other	2025-08-12
2025-03-31	$35,963,892	962,631	+2483.9%	Shares	Other	2025-05-12
2024-12-31	$1,687,649	37,255	+26.1%	Shares	Other	2025-02-12
2024-09-30	$1,736,060	29,555	+4.3%	Shares	Defined	2024-12-26
2024-06-30	$1,115,295	28,343	+16.5%	Shares	Defined	2024-12-26
2024-03-31	$1,616,927	24,333	+5.5%	Shares	Defined	2024-12-26
2023-12-31	$644,407	23,064	+74.3%	Shares	Defined	2024-12-26
2023-09-30	$281,884	13,234	—	Shares	Defined	2023-11-14
No filing history on record for this holder in this stock.